Color Doppler ultrasound differentiates Graves' disease from silent thyroiditis in thyrotoxicosis patients
Ultrasound blood flow patterns help distinguish Graves' disease from silent thyroiditis
This single-center prospective observational cohort study of 78 adults with thyrotoxicosis found that color Doppler ultrasound (CDU) with th…
A new study finds that measuring thyroid blood flow with ultrasound can help tell Graves' disease apart from silent thyroiditis, a key diagn…
Case report and review: IVIg and efgartigimod in Guillain-Barré with Graves disease and thyroid cancer
Doctors treat a rare relapse of Guillain-Barré syndrome with new immune therapies
This case report and literature review describes a 33-year-old man with Guillain-Barré syndrome, Graves disease, and papillary thyroid carci…
A 33-year-old man with Guillain-Barré syndrome found relief after doctors treated his underlying thyroid cancer and used new immune therapie…
Meta-analysis reports elevated IL-6 and IL-17 in thyroid eye disease patients
New Clues in Your Tears Could Change Thyroid Eye Disease Care
This meta-analysis of observational studies found that serum or tear levels of IL-6 and IL-17 were significantly higher in patients with thy…
Two inflammatory markers found in blood and tears are significantly higher in people with thyroid eye disease, offering new clues for faster…
Intravenous tocilizumab improves clinical activity in moderate-to-severe thyroid eye disease patients
Doctors spot four signs that predict which eye disease patients will heal fastest
This retrospective cohort study evaluated intravenous tocilizumab in 234 patients with moderate-to-severe thyroid eye disease at Beijing Ton…
A new study reveals four simple blood tests that tell doctors if a specific eye drug will work for you soon.
Secukinumab 300 mg subcutaneously failed to demonstrate overall response in adults with active Graves orbitopathy versus placebo
Secukinumab showed no benefit for active Graves orbitopathy patients
This randomized, double-blind, placebo-controlled trial evaluated secukinumab versus placebo in 28 adults with active, moderate-to-severe…
Secukinumab treatment for Graves orbitopathy showed no improvement in symptoms or eye measurements compared to placebo treatment.
COVID-19 pandemic associated with Hashimoto's increase and Subacute Thyroiditis decrease in Israeli retrospective cohort
Thyroid Disease Rates Shifted During Pandemic
This retrospective cohort study examined 4,765 incident thyroid disease cases among adults in Israel from January 2018 to December 2022.
You felt tired all the time. Maybe your hair started thinning.
Baseline vitamin D deficiency occurred in 73.08% of TAO patients receiving IVGC therapy with calcium supplementation
Simple Blood Test Could Predict Thyroid Eye Treatment Success
This retrospective cohort study evaluated 52 thyroid-associated ophthalmopathy patients treated with intravenous glucocorticoids and standar…
Checking vitamin D levels could help doctors choose the best treatment for thyroid eye disease.
Antithyroid drug-induced agranulocytosis patients show distinct T-cell receptor repertoires compared to Graves' disease patients
Why Your Thyroid Meds Might Trigger Rare Infections
This observational study compared immune receptor repertoires in patients with antithyroid drug-induced agranulocytosis (TiA) versus those w…
A rare but deadly reaction to thyroid drugs is linked to specific immune cell changes, offering clues to predict who's at risk before infect…
Questions about Graves' disease
Can IVIg and efgartigimod help a man with Graves disease and Guillain-Barré syndrome?
A case report shows a man with Graves disease and Guillain-Barré syndrome improved with IVIg and efgartigimod, but surgery was also needed after finding thyroid cancer.
Full answer →